ANNUAL REPORT 2007 | 2008 - Gimv
ANNUAL REPORT 2007 | 2008 - Gimv
ANNUAL REPORT 2007 | 2008 - Gimv
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
34. OFF-BALANCE SHEET OBLIGATIONS AND MAJOR PENDING LITIGATIONS (IN EUR 000)<br />
Name fund Year Currency Total<br />
commitment<br />
146 | <strong>Gimv</strong> Annual Report <strong>2007</strong>-<strong>2008</strong> | Statutory consolidation<br />
Total<br />
commitment 1<br />
CORPORATE INVESTMENT<br />
Buy out Fund 1999 EUR 12 400 12 400<br />
CapMan VIII Buyout 2006 EUR 20 000 20 000<br />
Corpeq Urals Fund2 1999 EUR 1 000 1 000<br />
DKB Emerging Europe L.P. 2001 USD 3 173 2 943<br />
Eagle Russia fund2 2006 USD 10 000 6 949<br />
EPF I 1996 EUR 1 524 1 524<br />
EPF II 2001 EUR 5 000 5 000<br />
EPF III 2006 EUR 5 000 5 000<br />
Fintech <strong>Gimv</strong> Fund <strong>2007</strong> USD 15 000 9 620<br />
Halder-<strong>Gimv</strong> Germany A2 2003 EUR 15 000 15 000<br />
Halder-<strong>Gimv</strong> Germany B2 2003 EUR 19 069 19 069<br />
Halder-<strong>Gimv</strong> Germany II <strong>2008</strong> EUR 81 250 81 250<br />
Industri Kapital 1997 EUR 3 500 3 500<br />
Kazakhstan Fund2 1997 EUR 2 000 4 432<br />
Lyceum Capital I 2000 EUR 75 000 75 000<br />
Lyceum Capital II <strong>2008</strong> GBP 21 000 26 389<br />
Nova Polonia 2000 EUR 10 450 10 450<br />
Pragma <strong>2007</strong> EUR 40 000 40 000<br />
Rabo Black Earth2 1996 EUR 300 242<br />
Rendex 1999 EUR 3 099 3 099<br />
Czech Fund2 2000 EUR 9 835 9 835<br />
Vectis 2004 EUR 3 000 3 000<br />
Outstanding<br />
commitment on<br />
31/03/08<br />
Value on<br />
31/03/08<br />
Total Corporate Investment 355 701 176 196 70 296<br />
CLEANTECH<br />
Emerald Technology Ventures II 2006 EUR 30 000 30 000<br />
Total Cleantech 30 000 21 694 8 009<br />
LIFE SCIENCES<br />
Abingworth Bio. II 1997 USD 3 006 4 193<br />
Abingworth Bio. IIIB 2001 USD 5 000 4 804<br />
Alta Biopharma Partners III 2004 USD 10 000 7 607<br />
Forward Ventures 4 2000 USD 5 000 4 729<br />
OBP II 1996 USD 1 000 882<br />
OBP II Annex 2002 USD 2 848 3 013<br />
OBP II Adj. 1996 USD 6 000 5 561<br />
OBP III 1999 USD 3 600 3 792<br />
OBP III Adjunct 1999 USD 14 400 14 786<br />
OBP IV 2001 USD 12 000 10 706<br />
Sofi nnova Venture III 1998 EUR 2 284 2 284<br />
Sofi nnova Venture IV 2000 EUR 10 000 10 000<br />
Sofi nnova Venture V (FR) 2005 EUR 7 500 7 500<br />
Total Life Sciences 79 859 5 548 37 093<br />
INFRASTRUCTURE<br />
DG Infra+ 3 <strong>2007</strong> EUR 30 000 30 000<br />
Total Infrastructure 30 000 27 413 2 588